GINA FANN: Open Payments
NPI 1114646189 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,711 in 69 payments from 28 companies in 2025. Trend: 2023 $1,508 · 2024 $3,248 · 2025 $1,711
Food & beverage: $1,516Education: $195
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $226 |
| PFIZER INC. | 9 | $189 |
| Merck Sharp & Dohme LLC | 5 | $106 |
| SEAGEN INC. | 1 | $100 |
| Astellas Pharma US Inc | 1 | $95 |
| ARRAY BIOPHARMA INC | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 3 | $80 |
| Janssen Biotech, Inc. | 3 | $80 |
| ABBVIE INC. | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
Products named: KISQALI, KEYTRUDA, Nubeqa, VENCLEXTA, ENHERTU, RYTELO, VERZENIO, LORBRENA.
Industry payments across FL — which companies pay providers there.
